发明名称 |
COMBINATION |
摘要 |
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, and N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof. |
申请公布号 |
EP2485593(A1) |
申请公布日期 |
2012.08.15 |
申请号 |
EP20100822733 |
申请日期 |
2010.10.08 |
申请人 |
GLAXOSMITHKLINE LLC |
发明人 |
DUMBLE, MELISSA;GILMER, TONA;KUMAR, RAKESH;LAQUERRE, SYLVIE;LEBOWITZ, PETER, F.;MORRIS, SHANNON, RENAE |
分类号 |
A61K31/4155;A61K31/506;A61P35/00 |
主分类号 |
A61K31/4155 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|